PATHOGENETIC EFFECTS OF COMBINATION THERAPY IN THE TREATMENT OF COMORBID PATHOLOGY
Open Access
- 16 June 2019
- journal article
- Published by LLC Information and Research Center Likarska Sprava in Likars'ka Sprava
- No. 4,p. 29-35
- https://doi.org/10.31640/jvd.4.2019(5)
Abstract
The objective of the work was to determine the possibility of drug correction of endothelial dysfunction, structural changes in peripheral arteries and the synthesis of end products of nitric oxide metabolism by the use of a combination of roflumilast and quercetin in the baseline therapy. In contrast to the baseline, the use of integrated therapy was followed in 6 months by a probable increase in the initial rate by 18.76 % (0.61 ± 0.04) m/s to (0.75 ± 0.04) m/s (t = 2.47; P < 0.05) and a probable decrease in the initial diameter of the brachial artery to (3.69 ± 0.29) mm (t = 2.49; P < 0.05). Patients of the experimental group have shown a significant increase in mean values of EDVD at the end of in-patient treatment and after 6 months of intensive supportive therapy (t = 2.17; Р < 0.05). The appointment of complex therapy after 6 months showed an increase in concentration in the blood of metabolites of NO in 1,3 times to (10.35 ± 1.89) μmol/l (t = 1.00; P > 0.1) at normal (12.05 ± 2.11) μmol/l. In patients of the index group after six months of the background therapy, IMT index has appeared in 1.07 times lower than the input data and has not reached the level of the control group. The IMT index for patients in the experimental group was considerably lower than the index before treatment (t = 0.31; P > 0.1). Application of complex therapy in patients with severe chronic obstructive pulmonary disease in the exacerbation phase in combination with stable coronary heart disease, stable angina pectoris I–II FK contributes to the restoration of endothelial function, improves structural changes in the peripheral arteries and has a stimulating effect on the synthesis of nitric oxide.Keywords
This publication has 10 references indexed in Scilit:
- Stratégie MNT: prévention comportementale vs prévention structurelleBulletin des Médecins Suisses, 2017
- Activation of apoptosis signalling pathways by reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Diabetic Nephropathy: Perspective on Novel Molecular MechanismsTrends in Endocrinology & Metabolism, 2016
- Nitric oxide signaling in yeastApplied Microbiology and Biotechnology, 2016
- An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapyFree Radical Biology & Medicine, 2016
- The Roles of Mitochondria in Autophagic Cell DeathCancer Biotherapy & Radiopharmaceuticals, 2016
- Redox mechanisms in age-related lung fibrosisRedox Biology, 2016
- Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseasesMechanisms of Ageing and Development, 2016
- Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cellsRedox Biology, 2016
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992